New cancer clinical trial: Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms
Published on: 2026-04-24T04:00:00Z
Conditions: Phase II; Imetelstat; Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases
Interventions: Drug: Imetelstat
Sponsors: M.D. Anderson Cancer Center; Geron Corporation
Not yet recruiting
https://ift.tt/0fUyoSc Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms
Conditions: Phase II; Imetelstat; Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases
Interventions: Drug: Imetelstat
Sponsors: M.D. Anderson Cancer Center; Geron Corporation
Not yet recruiting
https://ift.tt/0fUyoSc Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms
Comments
Post a Comment